Lessons From Implementation of the U.S. Preventive Services Task Force Recommendations for Lung Cancer Screening
Authors: Karina W. Davidson
Journal: Annals of Internal Medicine (2022)

EditorialsNovember 2022Lessons From Implementation of the U.S. Preventive Services Task Force Recommendations for Lung Cancer ScreeningKarina W. Davidson, PhD, MAScKarina W. Davidson, PhD, MAScInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, New York, New YorkSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M22-2886 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Approximately 130 000 deaths from lung cancer are expected in 2022, making it the most common cause of cancer death in the United States (1). In addition, more than 230 000 patients are expected to be diagnosed with lung cancer this year (1). As a result of this substantial disease burden, in 2014, the U.S. Preventive Services Task Force (USPSTF) published for the first time a recommendation for annual screening with low-dose computed tomography (LDCT) for persons aged 55 to 80 years who had a 30–pack-year smoking history and were currently smoking or had quit within the past 15 years (2). This ...References1. American Cancer Society. Cancer Facts & Figure 2022. American Cancer Society; 2022. Google Scholar2. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330-8. [PMID: 24378917] doi:10.7326/M13-2771 LinkGoogle Scholar3. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409. [PMID: 21714641] doi:10.1056/NEJMoa1102873 CrossrefMedlineGoogle Scholar4. Krist AH, Davidson KW, Mangione CM, et al; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962-70. [PMID: 33687470] doi:10.1001/jama.2021.1117 CrossrefMedlineGoogle Scholar5. Meza R, Jeon J, Toumazis I, et al. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: A Collaborative Modeling Study for the U.S. Preventive Services Task Force. (Evidence Syntheses, No. 198tr.) Agency for Healthcare Research and Quality; 2021. Google Scholar6. Silvestri GA, Goldman L, Burleson J, et al. Characteristics of persons screened for lung cancer in the United States. A cohort study. Ann Intern Med. 2022;175:1501-5. doi:10.7326/M22-1325 LinkGoogle Scholar7. Davidson KW, Mangione CM, Barry MJ, et al; US Preventive Services Task Force. Actions to transform US Preventive Services Task Force methods to mitigate systemic racism in clinical preventive services. JAMA. 2021;326:2405-11. [PMID: 34747970] doi:10.1001/jama.2021.17594 CrossrefMedlineGoogle Scholar8. Lim LS. In high-risk adults aged 50 to 80 y, USPSTF recommends annual lung cancer screening with LDCT (moderate certainty). Ann Intern Med. 2021;174:JC86. [PMID: 34339228] doi:10.7326/ACPJ202108170-086 LinkGoogle Scholar9. Smith HB, Ward R, Frazier C, et al. Guideline-recommended lung cancer screening adherence is superior with a centralized approach. Chest. 2022;161:818-25. [PMID: 34536385] doi:10.1016/j.chest.2021.09.002 CrossrefMedlineGoogle Scholar10. Krist AH, Davidson KW, Mangione CM, et al; US Preventive Services Task Force. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:265-79. [PMID: 33464343] doi:10.1001/jama.2020.25019 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Karina W. Davidson, PhD, MAScAffiliations: Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, New York, New YorkDisclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-2886.Corresponding Author: Karina W. Davidson, PhD, MASc, Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, 130 East 59th Street, Suite 14C, New York, NY 10022; e-mail, [email protected]edu.This article was published at Annals.org on 11 October 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCharacteristics of Persons Screened for Lung Cancer in the United States Gerard A. Silvestri , Lenka Goldman , Judy Burleson , Michael Gould , Ella A. Kazerooni , Peter J. Mazzone , M. Patricia Rivera , V. Paul Doria-Rose , Lauren S. Rosenthal , Michael Simanowith , Robert A. Smith , Nichole T. Tanner , and Stacey Fedewa Metrics November 2022Volume 175, Issue 11Page: 1608-1609KeywordsCancer screeningLung cancer screeningPreventive medicine ePublished: 11 October 2022 Issue Published: November 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...